Crescent Biopharma

Crescent Biopharma Inc is a biopharmaceutical company developing novel therapeutics to treat solid tumors, led by CR-001, a proprietary anti-PD-1/anti-VEGF bispecific antibody. Crescent believes CR-001 has the potential to deliver improved clinical efficacy and safety over pembrolizumab. CR-001 is a new molecular entity designed to replicate the functional properties of ivonescimab, a cooperative bispecific anti-PD-1/anti-VEGF antibody in development by Akeso Biopharma and Summit Therapeutics that delivered improved efficacy in a head-to-head Phase 3 clinical trial versus Keytruda in non-small cell lung cancer. Crescent is advancing its second and third programs, CR-002 and CR-003, which are antibody drug conjugates (ADCs) against validated oncology targets.

Crescent Biopharma Inc

News

Press Releases

Crescent Biopharma Completes Closing of Merger with GlycoMimetics and Previously Announced Private Placement of $200 Million

Management

Crescent Biopharma Appoints Jan Pinkas, Ph.D., as Chief Scientific Officer

Earnings

Crescent Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Crescent Biopharma to Present at September Investor Conferences

CBIO

Abeona Therapeutics

Achieve Life Sciences, Inc. - Common Shares

Achieve Life Sciences

Allogene Therapeutics, Inc. - Common Stock

Allogene Therapeutics

Arcturus Therapeutics Holdings Inc. - Common Stock

Arcturus Therapeutics

Assembly Biosciences, Inc. - Common Stock

Assembly Biosciences

Black Diamond Therapeutics, Inc. - Common Stock

Black Diamond Therapeutic

Cabaletta Bio

C4 Therapeutics

Caribou Biosciences

Eledon Pharmaceuticals, Inc. - Common Stock

Eledon Pharmaceuticals

Fennec Pharmaceuticals Inc. - Common Stock

Fennec Pharmaceuticals

Foghorn Therapeutics

Heron Therapeutics

Ironwood Pharmaceuticals, Inc. - Class A Common Stock

Ironwood Pharmaceuticals

Puma Biotechnology

Cartesian Therapeutics, Inc. - Common Stock

Cartesian Therapeutics

Sagimet Biosciences Inc. - Series A Common Stock

Sagimet Biosciences

Tiziana Life Sciences Ltd - Common Shares

Tiziana Life Sciences

TriSalus Life Sciences, Inc. - Common Stock

TriSalus Life Sciences

Tonix Pharmaceuticals Holding Corp. - Common Stock

Tonix Pharmaceuticals

Tenaya Therapeutics

Entrada Therapeutics, Inc. - Common Stock

Entrada Therapeutics

Voyager Therapeutics, Inc. - Common Stock

Voyager Therapeutics

Exagen

Zura Bio Limited - Class A Ordinary shares

Comments

Crescent Biopharma

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL